Literature DB >> 10639241

Direct Demonstration in Dogs of the Absence of Lethal Reperfusion Injury.

.   

Abstract

Entities:  

Year:  1997        PMID： 10639241     DOI： 10.1023/a:1017535509682

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  13 in total

Review 1.  The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?

Authors:  K A Reimer; C E Murry; V J Richard
Journal:  J Mol Cell Cardiol       Date:  1989-12       Impact factor: 5.000

2.  Intracellular plasma protein: a manifestation of cell injury in myocardial ischemia.

Authors:  S P Kent
Journal:  Nature       Date:  1966-06-18       Impact factor: 49.962

3.  Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.

Authors:  B A Khaw; H W Strauss; R Moore; J T Fallon; T Yasuda; H K Gold; E Haber
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

4.  Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

Authors:  J T Flaherty; B Pitt; J W Gruber; R R Heuser; D A Rothbaum; L R Burwell; B S George; D J Kereiakes; D Deitchman; N Gustafson
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

5.  Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.

Authors:  K Takeda; N D LaFrance; H F Weisman; H N Wagner; L C Becker
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

6.  Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence.

Authors:  A Farb; F D Kolodgie; M Jenkins; R Virmani
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

7.  Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.

Authors:  T C Wall; R M Califf; J Blankenship; J D Talley; M Tannenbaum; M Schwaiger; G Gacioch; M D Cohen; M Sanz; J D Leimberger
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

8.  The influence of reperfusin on infarct size after experimental coronary artery occlusion.

Authors:  M Hofmann; M Hofmann; K Genth; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Jul-Aug       Impact factor: 17.165

9.  Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2.

Authors:  L H Frame; J A Lopez; B A Khaw; J T Fallon; E Haber; W J Powell
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Absence of lethal reperfusion injury after 3 hours of reperfusion. A study in a single-canine-heart model of ischemia-reperfusion.

Authors:  D Zahger; J Yano; A Chaux; M C Fishbein; W Ganz
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690
View more
  1 in total

1.  Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury.

Authors:  Ehsan Y Davani; Zabrina Brumme; Gurpreet K Singhera; Hélène C F Côté; P Richard Harrigan; Delbert R Dorscheid
Journal:  Crit Care       Date:  2003-10-10       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.